About
A spin-out from the University of Oxford, Vivid Dx is a precision diagnostics company transforming pathogen detection and antimicrobial resistance (AMR). The company is developing a next-generation platform to deliver broad pathogen ID in 30 minutes and phenotypic antibiotic susceptibility testing (AST) in 3 hours – directly from blood, with no blood culture required. By combining novel pathogen cell isolation, Raman spectroscopy, a proprietary Raman spectra database, and advanced AI/ML, the platform has the potential to redefine the speed, accuracy, and clinical utility of infectious disease diagnostics. The company is backed by Oxford Science Enterprises and other leading investors.
Technologies
Outlook
Microsoft Office 365
Squarespace ECommerce
Mobile Friendly
Keywords
medical equipment manufacturing
sepsis detection
biotechnology
real-time pathogen detection
disruptive healthcare technology
phenotypic ast
broad pathogen detection
clinical validation
metabolic activity testing
fast pathogen id
ai-enhanced spectral interpretation
spectroscopy-based diagnostics
biochemical fingerprint
direct-from-blood testing
healthcare equipment & supplies manufacturing
ai and machine learning
microfluidic phenotypic testing
rapid antimicrobial susceptibility
rapid diagnostics
disruptive diagnostics
precision diagnostics
culture-free ast
ai-driven spectral analysis
blood pathogen id
healthtech
single-cell raman fingerprint
metabolic activity raman assay
raman spectroscopy
spectroscopy for sepsis
next-generation diagnostics
Company Information
-
Employees 13
-
Founded 2022
Location
United Kingdom
